Bio interaction News
-
EVŌQ Nano CEO Shaun Rothwell Discusses Advanced Antimicrobial Solution EVQ-218 and Its Impact on AMR
Bio interaction | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 06 Nov, 2024
In an insightful interview with BioSpectrum Asia, Shaun Rothwell, CEO of EVŌQ Nano, reveals the transformative potentia...Read more
-
Bio interaction | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 14 Oct, 2024
In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cross...Read more
-
mRNA as novel active ingredient – PlasmidFactory providing the template for tomorrow’s vaccines
Bio interaction | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 02 Sep, 2024
Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...Read more
-
Pierre-Alain Ruffieux Joins Cytiva as COO, Sets Sights on Asia Pacific Growth
Bio interaction | Opinion | By Ankit Kankar | ankit.kankar@mmactiv.com | 2 Comment | 04 Jul, 2024
On July 1, 2024, Cytiva significantly bolstered its leadership team by appointing Pierre-Alain Ruffieux as Chief...Read more
-
Importance of HPV Testing and Genotyping in Cervical Cancer Prevention
Bio interaction | Opinion | 3 Comment | 02 May, 2023
Dr. Mohd Azizuddin bin Mohd Yussof, CT (IAC), Bsc. (Biomedical), MHealthSc. (Biomedical), PhD (Pathology) is the Directo...Read more
-
Driving healthcare digitization on integrated platforms to optimize care value chain
Bio interaction | Opinion | By Hithaishi C Bhaskar | 3 Comment | 23 Mar, 2023
Growing trends in healthcare digitalization are continuously transforming execution and practices in the ...Read more
-
Elevating Life science industry standards through the implementation of quality practices
Bio interaction | Analysis | 2 Comment | 10 Mar, 2023
Lifescience Laboratory workflows, products and services are complex and can be difficult to manage due to long and strin...Read more
-
Taking a patient-centric approach to value-based care in APAC
Bio interaction | Analysis | By Tim Morris, Commercial Portfolio and Partnership Director for Elsevier | 2 Comment | 10 Mar, 2023
The value-based care model is gaining momentum in the healthcare industry, and it is not hard to see why. After al...Read more
-
Integrated Health Corridors can deliver quality healthcare across emerging markets
Bio interaction | Analysis | 2 Comment | 09 Feb, 2023
Accessibility to quality healthcare is commonly regarded as a fundamental human right for every person. This is outlined...Read more
-
Singapore is beginning to see benefits of investing in technological aspect of cancer treatment
Bio interaction | Opinion | By Chew Huat Seng, Managing Director, Hitachi Asia, Malaysia | 5 Comment | 06 Feb, 2023
Medicine and technology have made tremendous strides toward defeating one of the deadliest diseases of the world, despit...Read more
-
VALUE is the Trending Word of 2023
Bio interaction | Opinion | By Steve Peretz, Group Director (Health Experience and Product Strategy), Appnovation, AMER | 0 Comment | 06 Feb, 2023
The last two years saw a significant leap toward patient-centricity in the pharmaceutical space. In 2023, that trend wil...Read more
-
Bio interaction | Influencers | 6 Comment | 06 Feb, 2023
What are the barriers to access that are impacting patient outcomes in managing antimicrobial resistance? Why do they ...Read more
-
Bio interaction | Opinion | By Hithaishi C Bhaksar | 5 Comment | 16 Jan, 2023
How crucial is the adaptation of next-generation TCR cell therapies for diagnostic and prophylactic purposes? TCR cell ...Read more
-
Bio interaction | Opinion | By Hithaishi C Bhaskar | 5 Comment | 16 Jan, 2023
Why does multiple sclerosis (MS) deserve attention and investment in APAC for the development of novel treatments? ...Read more
-
"Innovations that serve a purpose, paired with a good go-to-market strategy are attractive for VCs"
Bio interaction | Opinion | By Hithaishi C Bhaskar | 3 Comment | 06 Jan, 2023
In 2016, the Singapore government committed to a S$4 billion budget to drive research and commercialisation activities i...Read more
-
"Crovalimab could potentially become the first global drug originating from Singapore"
Bio interaction | Opinion | By Hithaishi C Bhaskar | 3 Comment | 06 Jan, 2023
Japanese headquartered Chugai Pharmaceutical has already developed world-class technologies for antibody engineeri...Read more
-
Propelling Genomic Research and Public Health with Future-Proof Digital Infrastructure
Bio interaction | Analysis | 4 Comment | 07 Dec, 2022
Digital transformation in healthcare has been at breakneck speed since the outbreak of the COVID-19 pandemic. It took ju...Read more
-
Effective policy design improves healthcare outcomes while containing costs
Bio interaction | Opinion | By Hithaishi C Bhaskar | 6 Comment | 06 Dec, 2022
MiyaHealth, a Singapore based health technology company is transforming this space, to create a much needed data reposit...Read more
